Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 705-718
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.705
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.705
Figure 2 Immunohistochemical staining (400 ×).
A: Loss of nuclear expression for ATRX in pancreatic neuroendocrine tumor G3; B and C: Aberrant expression for p53 (B) and loss of expression of Rb1 (C) in pancreatic neuroendocrine carcinoma.
- Citation: Zhang MY, He D, Zhang S. Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment. World J Gastrointest Oncol 2020; 12(7): 705-718
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/705.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.705